Related references
Note: Only part of the references are listed.Ligand-induced internalization of the orexin OX1 and cannabinoid CB1 receptors assessed via N-terminal SNAP and CLIP-tagging
Richard J. Ward et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Unidirectional Cross-Activation of GRPR by MOR1D Uncouples Itch and Analgesia Induced by Opioids
Xian-Yu Liu et al.
CELL (2011)
Dopamine Receptor Homooligomers and Heterooligomers in Schizophrenia
Melissa L. Perreault et al.
CNS NEUROSCIENCE & THERAPEUTICS (2011)
AT1R-CB1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II
Raphael Rozenfeld et al.
EMBO JOURNAL (2011)
Functional potencies of dopamine agonists and antagonists at human dopamine D2 and D3 receptors
Yoshihiro Tadori et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Separation and reformation of cell surface dopamine receptor oligomers visualized in cells
Brian F. O'Dowd et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Dopamine D4 receptor oligomerization - contribution to receptor biogenesis
Kathleen Van Craenenbroeck et al.
FEBS JOURNAL (2011)
Heteromultimerization of Cannabinoid CB1 Receptor and Orexin OX1 Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin A
Richard J. Ward et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Full characterization of GPCR monomer-dimer dynamic equilibrium by single molecule imaging
Rinshi S. Kasai et al.
JOURNAL OF CELL BIOLOGY (2011)
CODA-RET reveals functional selectivity as a result of GPCR heteromerization
Eneko Urizar et al.
NATURE CHEMICAL BIOLOGY (2011)
Asymmetry of GPCR oligomers supports their functional relevance
Pascal Maurice et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance
Ahmed Hasbi et al.
MOLECULAR BRAIN (2011)
Applications of fluorescence and bioluminescence resonance energy transfer to drug discovery at G protein coupled receptors
Elisa Alvarez-Curto et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)
Dopamine D2-D3 receptor heteromers: pharmacological properties and therapeutic significance
Roberto Maggio et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Time-resolved FRET between GPCR ligands reveals oligomers in native tissues
Laura Albizu et al.
NATURE CHEMICAL BIOLOGY (2010)
Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes
Nicola J. Smith et al.
PHARMACOLOGICAL REVIEWS (2010)
Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules
Jonathan A. Hern et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Increased Abundance of Opioid Receptor Heteromers After Chronic Morphine Administration
Achla Gupta et al.
SCIENCE SIGNALING (2010)
[H-3]4-(Dimethylamino)-N-(4-(4-(2-Methoxyphenyl)Piperazin-1-yl)Butyl)Benzamide: A Selective Radioligand for Dopamine D-3 receptors. II. Quantitative Analysis of Dopamine D-3 and D-2 Receptor Density Ratio in the Caudate-Putamen
Jinbin Xu et al.
SYNAPSE (2010)
Cocaine Self-Administration Markedly Increases Dopamine D2 Receptor Negative Cooperativity for dopamine Binding: A Receptor Dimer-Based Analysis
Rafael Franco et al.
SYNAPSE (2010)
Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization
Min Wang et al.
MOLECULAR BRAIN (2010)
GPCR Theme Editorial
G. Milligan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function
Graeme Milligan
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation
Yang Han et al.
NATURE CHEMICAL BIOLOGY (2009)
Analysis of receptor oligomerization by FRAP microscopy
Sandra Dorsch et al.
NATURE METHODS (2009)
Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance
Roberto Maggio et al.
PARKINSONISM & RELATED DISORDERS (2009)
Dopamine D2 receptors form higher order oligomers at physiological expression levels
Wen Guo et al.
EMBO JOURNAL (2008)
G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors
J. Robert Lane et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization
Damien Maurel et al.
NATURE METHODS (2008)
Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: Potential role of heterodimer formation
Roberto Maggio et al.
PARKINSONISM & RELATED DISORDERS (2008)
Neuronal, Gq/11-coupled dopamine receptors: an uncharted role for dopamine
Asim J. Rashid et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 - Co-immunoprecipitation and fluorescence resonance energy transfer analysis
Alessandra Baragli et al.
CELLULAR SIGNALLING (2007)
Novel pharmacological applications of G-protein-coupled receptor-G protein fusions
Graeme Milligan et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D2L receptors are modified by co-transfection of D3 receptors:: potential role of heterodimer fort-nation
Francesca Novi et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Protean agonism at the dopamine D2 receptor:: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of Go1 but an antagonist/inverse agonist for Gi1, Gi2, and Gi3
J. Robert Lane et al.
MOLECULAR PHARMACOLOGY (2007)
G protein-coupled receptor dimerisation: Molecular basis and relevance to function
Graeme Milligan
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function
James Ellis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Gz proteins are functionally coupled to dopamine D2-like receptors in vivo
Kwong J. Leck et al.
NEUROPHARMACOLOGY (2006)
Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning
C Kellendonk et al.
NEURON (2006)
Dopamine D3 receptor antagonists as therapeutic agents
JN Joyce et al.
DRUG DISCOVERY TODAY (2005)
The influence of G protein subtype on agonist action at D2 dopamine receptors
SA Nickolls et al.
NEUROPHARMACOLOGY (2004)
Dimerization of α1-adrenoceptors
G Milligan et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins
JJ Carrillo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
D2 dopamine receptor homodimerization is mediated by multiple sites of interaction, including an intermolecular interaction involving transmembrane domain 4
SP Lee et al.
BIOCHEMISTRY (2003)
Potent activation of dopamine D-3/D-2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole
R Maggio et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes
MJ Millan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization
M Pfeiffer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A single subunit (GB2) is required for G-protein activation by the heterodimeric GABAB receptor
B Duthey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Function of GB1 and GB2 subunits in G protein coupling of GABAB receptors
M Margeta-Mitrovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Dopamine D2 receptor dimer formation -: Evidence from ligand binding
D Armstrong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment:: Influence of withdrawal period
JN Joyce
SYNAPSE (2001)
Homo- and heterodimerization of somatostatin receptor subtypes -: Inactivation of sst3 receptor function by heterodimerization with sst2A
M Pfeiffer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
